about
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, ...
Read More
1.36
-0.07
(-4.90%)
116.7K
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for FibroBiologics Inc is on 22 Sep 2026 for the purpose of RedChip Investor Webinar with FibroBiologics
See details
Not Eligible
Expensive Valuation
Technically Bearish
FibroBiologics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..